Skip to main content
. 2017 Aug 13;2017:9852632. doi: 10.1155/2017/9852632

Figure 2.

Figure 2

Breast cancer patient (51 years old) evaluated by F18-FDG-PET/CT showing two bone marrow metastatic lesions on baseline scan (a) which progressed to FDG-positive osteolytic metastatic bone lesions on 3 mo follow-up scan (b).